ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

Amgen, J&J Defend ESA Indications.

March 21, 2008

Cancer Control Emphasis Shift to Prevention Projected For Y 1978; Advisors Seek More

July 29, 1977

In Brief: Hayard Of Sloan-Kettering, Leder Of Harvard to Share 1985 Bristol-Myer Award Of $50,000

March 29, 1985

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986

Program Announcement; NCI Seeks Studies Of Breast Cancer In Northeast U.S.

January 22, 1993